Ved Prakash Dwivedi

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Venues

Microbiology spectrum

PLoS pathogens

Cellular & molecular immunology

The Journal of infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Isha Pahuja, Antara Ghoshal, Ahmed Abdallah Okieh, Akanksha Verma, Kriti Negi, Meetu Agarwal, Nidhi Subhash Chandra, Saurabh Kumar Sharma, Ashima Bhaskar, Ved Prakash Dwivedi
Immunoinhibitory effects of anti-tuberculosis therapy induce the host vulnerability to tuberculosis recurrence. Microbiology spectrum 12 (7) (2024)
Isha Pahuja, Antara Ghoshal, Ahmed Abdallah Okieh, Akanksha Verma, Kriti Negi, Meetu Agarwal, Nidhi Subhash Chandra, Saurabh Kumar Sharma, Ashima Bhaskar, Ved Prakash Dwivedi
Immunoinhibitory effects of anti-tuberculosis therapy induce the host vulnerability to tuberculosis recurrence. Microbiology spectrum 12 (7) (2024)
Isha Pahuja, Antara Ghoshal, Ahmed Abdallah Okieh, Akanksha Verma, Kriti Negi, Meetu Agarwal, Nidhi Subhash Chandra, Saurabh Kumar Sharma, Ashima Bhaskar, Ved Prakash Dwivedi
Immunoinhibitory effects of anti-tuberculosis therapy induce the host vulnerability to tuberculosis recurrence. Microbiology spectrum 12 (7) (2024)
Isha Pahuja, Antara Ghoshal, Ahmed Abdallah Okieh, Akanksha Verma, Kriti Negi, Meetu Agarwal, Nidhi Subhash Chandra, Saurabh Kumar Sharma, Ashima Bhaskar, Ved Prakash Dwivedi
Immunoinhibitory effects of anti-tuberculosis therapy induce the host vulnerability to tuberculosis recurrence. Microbiology spectrum (2024)
Isha Pahuja, Kriti Negi, Anjna Kumari, Meetu Agarwal, Suparba Mukhopadhyay, Babu Mathew, Shivam Chaturvedi, Jaswinder Singh Maras, Ashima Bhaskar, Ved Prakash Dwivedi
Berberine governs NOTCH3/AKT signaling to enrich lung-resident memory T cells during tuberculosis. PLoS pathogens 19 (3) (2023)
Isha Pahuja, Kriti Negi, Anjna Kumari, Meetu Agarwal, Suparba Mukhopadhyay, Babu Mathew, Shivam Chaturvedi, Jaswinder Singh Maras, Ashima Bhaskar, Ved Prakash Dwivedi
Berberine governs NOTCH3/AKT signaling to enrich lung-resident memory T cells during tuberculosis. PLoS pathogens 19 (3) (2023)
Isha Pahuja, Kriti Negi, Anjna Kumari, Meetu Agarwal, Suparba Mukhopadhyay, Babu Mathew, Shivam Chaturvedi, Jaswinder Singh Maras, Ashima Bhaskar, Ved Prakash Dwivedi
Berberine governs NOTCH3/AKT signaling to enrich lung-resident memory T cells during tuberculosis. PLoS pathogens 19 (3) (2023)
Dhiraj Kumar Singh, Ashima Bhaskar, Isha Pahuja, Aishwarya Shaji, Barnani Moitra, Yufang Shi, Ved Prakash Dwivedi, Gobardhan Das
Co-treatment with Clofazimine and Rapamycin eliminates drug-resistant tuberculosis by inducing polyfunctional central memory T cell responses. The Journal of infectious diseases (2023)
Kriti Negi, Meetu Agarwal, Isha Pahuja, Bhavya Bhardwaj, Mansi Rawat, Ashima Bhaskar, Ved Prakash Dwivedi
Combating the challenges of COVID-19 pandemic: Insights into molecular mechanisms, immune responses and therapeutics against SARS-CoV-2. Oxford open immunology 4 (1) (2023)
Baldeep Singh, Isha Pahuja, Priyanka Yadav, Aishwarya Shaji, Shivam Chaturvedi, Anand Ranganathan, Ved Prakash Dwivedi, Gobardhan Das
Adjunct therapy with all-trans-retinoic acid improves therapeutic efficacy through immunomodulation while treating tuberculosis with antibiotics in a murine model. The Journal of infectious diseases (2023)
Anjna Kumari, Isha Pahuja, Kriti Negi, Antara Ghoshal, Suparba Mukopadhyay, Meetu Agarwal, Babu Mathew, Jaswinder Singh Maras, Shivam Chaturvedi, Ashima Bhaskar, Ved Prakash Dwivedi
Withaferin A Protects against Primary and Recurrent Tuberculosis by Modulating Mycobacterium-Specific Host Immune Responses. Microbiology spectrum (2023)
Annu Devi, Isha Pahuja, Shashi Prakash Singh, Akanksha Verma, Debapriya Bhattacharya, Ashima Bhaskar, Ved Prakash Dwivedi, Gobardhan Das
Revisiting the role of mesenchymal stem cells in tuberculosis and other infectious diseases. Cellular & molecular immunology (2023)
Isha Pahuja, Akanksha Verma, Antara Ghoshal, Suparba Mukhopadhyay, Anjna Kumari, Aishwarya Shaji, Shivam Chaturvedi, Ved Prakash Dwivedi, Ashima Bhaskar
Biapenem, a Carbapenem Antibiotic, Elicits Mycobacteria Specific Immune Responses and Reduces the Recurrence of Tuberculosis. Microbiology spectrum (2023)
Isha Pahuja, Kriti Negi, Anjna Kumari, Meetu Agarwal, Suparba Mukhopadhyay, Babu Mathew, Shivam Chaturvedi, Jaswinder Singh Maras, Ashima Bhaskar, Ved Prakash Dwivedi
Berberine governs NOTCH3/AKT signaling to enrich lung-resident memory T cells during tuberculosis. PLoS pathogens 19 (3) (2023)
Annu Devi, Isha Pahuja, Shashi Prakash Singh, Akanksha Verma, Debapriya Bhattacharya, Ashima Bhaskar, Ved Prakash Dwivedi, Gobardhan Das
Revisiting the role of mesenchymal stem cells in tuberculosis and other infectious diseases. Cellular & molecular immunology (2023)
Mona Singh, Santosh Kumar, Baldeep Singh, Preeti Jain, Anjna Kumari, Isha Pahuja, Shivam Chaturvedi, Durbaka Vijay Raghava Prasad, Ved Prakash Dwivedi, Gobardhan Das
The 1, 2-ethylenediamine SQ109 protects against tuberculosis by promoting M1 macrophage polarization through the p38 MAPK pathway. Communications biology 5 (1) (2022)
Ashima Bhaskar, Santosh Kumar, Mehak Zahoor Khan, Amit Singh, Ved Prakash Dwivedi, Vinay Kumar Nandicoori
Host sirtuin 2 as an immunotherapeutic target against tuberculosis. eLife 9 (2020)

Ved Prakash Dwivedi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ved Prakash Dwivedi